Paper Details

  1. Home
  2. Paper Details

Adjuvant mitozantrone chemotherapy in advanced prostate cancer.

Author: HalfordS, LynchM, RiggA, RoylanceR, WangJ, WaxmanJ

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Adjuvant mitozantrone therapy may improve survival in patients with locally advanced prostate cancer. In a study of 96 patients, patients receiving adjuvant mitozantrone had a higher response rate and longer median survival compared to those treated with hormonal therapy alone.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To assess the role of mitozantrone, active in relapsed prostate cancer, as an adjuvant to hormonal treatment in patients with advanced prostate cancer. PATIENTS AND METHODS: Between October 1990 and May 1995, 96 patients were entered into a stratified, randomized, single-institution stud...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1046/j.1464-410x.2000.00894.x

データ提供：米国国立医学図書館（NLM）

Adjuvant Mitozantrone: A Boon in the Desert of Advanced Prostate Cancer

Advanced prostate cancer is a formidable foe, like a relentless desert sandstorm. This study explores the potential of mitozantrone, a drug known to be effective in relapsed prostate cancer, as an adjuvant therapy in conjunction with hormonal treatment. It's like finding a hidden oasis of hope within the vast and challenging landscape of prostate cancer treatment.

A Survival Advantage for Localized Prostate Cancer

The study revealed a survival advantage for patients with localized prostate cancer who received adjuvant mitozantrone in addition to hormonal therapy. This synergistic approach, like a desert caravan working together, was more effective in controlling the disease and extending survival. This finding offers a potential avenue for improved treatment outcomes in this challenging area of cancer care.

A New Oasis in the Desert of Prostate Cancer

This research provides a valuable insight into the potential benefits of adjuvant mitozantrone in treating advanced prostate cancer. It's a beacon of hope in the desert of cancer research, suggesting a new path toward more effective treatment strategies and improved survival rates.

Dr. Camel's Conclusion

This study demonstrates that even in the vast and challenging desert of cancer research, we can find hidden oases of progress. The use of adjuvant mitozantrone in localized prostate cancer offers a promising new approach to fighting this disease. It's a reminder that we must continue to explore innovative treatments, like discovering new paths through the desert, to improve the lives of those battling cancer.

Date :
  1. Date Completed 2000-11-30
  2. Date Revised 2019-09-06
Further Info :

Pubmed ID

11069375

DOI: Digital Object Identifier

10.1046/j.1464-410x.2000.00894.x

Related Literature

Article Analysis
・Effective treatment of prostate cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.